Amenorrhea
- 1.Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea: a committee opinion. Fertil Steril. 2024;122(1):52-61.
- 2.Solnik MJ. Evaluation of primary amenorrhea. BMJ Best Practice. Updated August 11, 2026. Accessed October 1, 2026. https://bestpractice.bmj.com/topics/en-us/1101
- 3.Klein DA, Paradise SL, Reeder RM. Amenorrhea: a systematic approach to diagnosis and management. Am Fam Physician. 2019;100(1):39-48.
- 4.Fowler LR, Gillard C, Morain SR. Readability and accessibility of terms of service and privacy policies for menstruation-tracking smartphone applications. Health Promot Pract. 2020;21(5):679-683.
- 5.Mohan S, Jenkins J. Flowing data: women’s views and experiences on privacy and data security when using menstrual cycle tracking apps. Oxf Open Digit Health. 2025;3:oqaf011.
- 6.Logue DM, Madigan SM, Melin A, et al. Low energy availability in athletes 2020: an updated narrative review of prevalence, risk, within-day energy balance, knowledge, and impact on sports performance. Nutrients. 2020;12(3):835.
- 7.Centers for Disease Control and Prevention. Contraception. Injectables. November 19, 2024. Accessed July 21, 2026. https://www.cdc.gov/contraception/hcp/usspr/injectables.html
- 8.Osoti A, Kidula N, Mengesa LB, et al. Return to fertility after subcutaneous depot medroxyprogesterone acetate: a narrative review. BMJ Sex Reprod Health. 2025;51:s52-s59.
- 9.Sergison JE, Maldonado LY, Gao X, et al. Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis. Am J Obstet Gynecol. 2019;220(5):440-448.e8.
- 10.Centers for Disease Control and Prevention. Intrauterine contraception. November 19, 2024. Accessed July 21, 2026. https://www.cdc.gov/contraception/hcp/usspr/intrauterine-contraception.html
- 11.Curtis KM, Nguyen AT, Tepper NK, et al. U.S. selected practice recommendations for contraceptive use, 2024. MMWR Recomm Rep. 2024;73(3):1-77.
- 12.Stuenkel CA, Gompel A. Primary ovarian insufficiency. N Engl J Med. 2023;388(2):154-163.
- 13.Yatsenko SA, Witchel SF, Gordon CM. Primary amenorrhea and premature ovarian insufficiency. Endocrinol Metab Clin North Am. 2024;53(2):293-305.
- 14.Teede HJ, Tay CT, Laven JJE, et al.; International PCOS Network. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189(2):G43-G64.
- 15.American Society for Reproductive Medicine. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polyendocrine Metabolic Ovarian Syndrome. October 2023. Accessed July 21, 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polyendocrine-metabolic-ovarian-syndrome-2023/
- 16.Kalsi AK, Halder A, Jain M, et al. Prevalence and reproductive manifestations of macroprolactinemia. Endocrine. 2019;63(2):332-340.
- 17.Samson SL, Hamrahian AH, Ezzat S; Neuroendocrine AACE and Pituitary Scientific Committee. American College of Endocrinology (ACE). American Association of Clinical Endocrinologists, American College of Endocrinology disease state clinical review: clinical relevance of macroprolactin in the absence or presence of true hyperprolactinemia. Endocr Pract. 2015;21(12):1427-1435.
- 18.Stuenkel CA. Cynthia Stuenkel, MD, talks evaluating and managing primary ovarian insufficiency. Contemporary OB/GYN. October 24, 2025. Accessed July 21, 2026. https://www.contemporaryobgyn.net/view/cynthia-stuenkel-md-talks-evaluating-and-managing-primary-ovarian-insufficiency
- 19.Teede HJ, Khomami MB, Morman R, et al.; Global Name Change Consortium. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026;407(10545):2329-2339.
- 20.Christianson MS, King JA, Zacur HA. Clinical Gynecology. ChristiansonMSKingJAZacurHA. Hyperprolactinemia. In: BieberEJSanfilippoJSHorowitzIRet al., eds. Clinical Gynecology. Cambridge University Press; 2015:929-941.
- 21.Wong L, Leibner L, Vicioso C, et al. Functional hypothalamic amenorrhea in adolescent athletes impairs bone accrual and increases fracture risk. Front Endocrinol (Lausanne). 2025;16:1709695.
- 22.Meczekalski B, Niwczyk O, Bala G, et al. Managing early onset osteoporosis: the impact of premature ovarian insufficiency on bone health. J Clin Med. 2023;12(12):4042.
- 23.Tay CT, Mousa A, Vyas A, et al. 2023 international evidence-based polycystic ovary syndrome guideline update: insights from a systematic review and meta-analysis on elevated clinical cardiovascular disease in polycystic ovary syndrome. J Am Heart Assoc. 2024;13(16):e033572.
Read the full edition
Get immediate access, anytime, anywhere.
Choose a single edition, 1-year or 2-year full-access subscription.
Earn 4 CME credits for this edition.
